A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies

NCT05329766 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

332

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastrointestinal Tract Malignancies

Interventions

DRUG: Domvanalimab
DRUG: Quemliclustat
DRUG: Zimberelimab
DRUG: Fluorouracil
DRUG: Leucovorin
DRUG: Oxaliplatin

Sponsor

Arcus Biosciences, Inc.

Collaborators

[object Object]